Salix Pharma Commences Cash Tender Offer For Santarus Stock - Quick Facts

(RTTNews) - Salix Pharmaceuticals, Ltd. (SLXP) announced the commencement of a cash tender offer by its indirect subsidiary, Willow Acquisition Sub Corporation, to purchase all of the issued and outstanding shares of common stock, par value $0.0001 per share, of Santarus, Inc. (SNTS) at a purchase price of $32.00 per share, net to the seller in cash.

The tender offer is being made pursuant to an Offer to Purchase, dated December 3, 2013, and in connection with the previously announced definitive merger agreement, dated November 7, 2013.

The tender offer is scheduled to expire at 12:00 Midnight, New York City time, at the end of the day on December 31, 2013.